Takeda Pharmaceutical Co. Ltd (TKPHF)

$32.32 0.00 (0.00%)

14:42 EDT TKPHF Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range -

52-Week Range $25.07 - $34.27

Dividend & Yield N/A (N/A)

TKPHF Stock Predictions, Articles, and Takeda Pharmaceutical Co. Ltd News

From the Web

Why Shares of Phathom Pharmaceutical Jumped This Week

From The Motley Fool Jan 28, 2023

Investors are reading between the lines to see if the company is fixing its problems regarding its lead therapy.

Takeda Pharma Clocks 1% Increase In FY21 Core Profit, Expects Growth Momentum In FY22

From Benzinga May 11, 2022

Takeda's Maribavir Reduces Hospitalization Rates, Hospital Stay In Post-Transplant Infection Patients

From Benzinga Apr 22, 2022

Takeda's Angioedema Drug Shows Promising Action Against COVID-19 Infection

From Benzinga Mar 8, 2022

Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Firazyr (icatibant), used to treat a blood vessel condition called angioedema, has shown promise as a treatment for COVID...

Roche And AstraZeneca Settle Ultomiris Patent Lawsuit

From Benzinga Feb 22, 2022

Roche Holdings AG (OTC: RHHBY) has decided to close out a patent infringement lawsuit against AstraZeneca plc (NASDAQ: AZN), centering around the latter's newly...

Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics

From Benzinga Feb 22, 2022

Takeda Pharmaceutical Co Ltd (NYSE: TAK) has signed up for a gene therapy pact, encoding a $2 billion biobucks deal with Code Biotherapeutics across four...